J&J's "My Health Can't Wait" campaign encourages consumers to continue with routine health care including preventive care and routine exams. The company has created a website with resources for consumers and health care providers.
The Texas Department of State Health Services had to shift its influencer-led COVID-19 safety campaign after facing difficulties finding influencers when the message changed from staying at home to going out safely. The campaign collectively garnered more than 37 million engagements, including 33.6 million TikTok views.
Digital marketing is about to become "the new battleground for brand-building" as consumers continue to shop from home, political activism increases and 5G rollouts continue, writes PMG's Tim Lardner. He offers five steps to take now so marketers can prepare for "the most competitive three-month stretch in digital marketing and media."
Gilead Sciences agreed to a $97 million settlement to resolve accusations that it used a patient foundation as a conduit to improperly cover copayments of Medicare patients taking the firm's pulmonary arterial hypertension drug Letairis from 2007 to 2010. Gilead denies any wrongdoing and says it made the donations "following guidance issued by the U.S. Department of Health and Human Services that permits companies to make donations to assist patients with their required copays for medications."
A federal appeals court overturned a district court ruling that allowed an unprecedented "negotiation class" of 33,000 cities, towns and counties to participate and vote on opioid settlement deals proposed by drug firms and distributors. "However well-intentioned the district court's actions might be, the fact of the matter is that the court, when it certified the negotiation class, exercised power it did not have," Judge Eric Clay wrote.
The FDA has given emergency use authorization to Quadrant Biosciences for its COVID-19 test kit. The agency also authorized OraSure Technologies' ORAcollect-RNA device to be used with the test for the collection of saliva swab samples.
The FDA has reissued an emergency use authorization for point-of-care use to the Assure COVID-19 IgG/IgM rapid test. "Authorizing point-of-care serology tests will enable more timely and convenient results for individuals who want to understand if they have previously been infected with the virus that causes COVID-19," said FDA Commissioner Stephen Hahn.
European regulators have given CE mark approval to BGI Genomics for two multiplexed tests that can detect and differentiate SARS-CoV-2, influenza A and influenza B.
The Quicklear mechanical thrombectomy system, an all-in-one catheter and aspiration pump that is used to remove blood clots from the vessels of the peripheral arterial and venous systems, has been released by Royal Philips in the US after receiving 510(k) clearance from the FDA.
- Page 1